The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
W G Rice, C A Schaeffer, L Graham, M Bu, J S McDougal, S L Orloff, F Villinger, M Young, S Oroszlan, M R Fesen
Index: Proc. Natl. Acad. Sci. U. S. A. 90 , 9721, (1993)
Full Text: HTML
Abstract
The C-nitroso compound 3-nitrosobenzamide, which has been shown to remove zinc from the retroviral-type zinc finger of p7NC nucleocapsid proteins, inhibits acute infection of human immunodeficiency virus type 1 in cultured human lymphocytes. The attachment of the virus to lymphocytes and the activities of critical viral enzymes, such as reverse transcriptase, protease, and integrase, are not affected by 3-nitrosobenzamide. However, the process of reverse transcription to form proviral DNA is effectively abolished by the drug, identifying the mode of action of 3-nitrosobenzamide as interrupting the role of p7NC in accurate proviral DNA synthesis during the infectious phase of the virus life cycle.
Related Compounds
Related Articles:
1993-07-12
[FEBS Lett. 326 , 140, (1993)]
2012-07-03
[Proc. Natl. Acad. Sci. U. S. A. 109(27) , 10793-7, (2012)]
2010-09-01
[Nat. Chem. Biol. 6(9) , 641-3, (2010)]
1998-04-23
[J. Med. Chem. 41(9) , 1371-81, (1998)]
1993-02-04
[Nature 361 , 473, (1993)]